Formulation, characterization and in vivo evaluation of self-nanoemulsifying drug delivery system for oral delivery of Valsartan

Current Nanoscience

Volumn 10, Issue 2, 2014, Pages 263-270

  Chopra, Maulick ^a   Nayak, Usha Y ^a   Gurram, Aravind Kumar ^a   Sreenivasa Reddy, M ^a   Koteshwara, K B ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Bioavailability; Pharmacokinetics study; Self nanoemulsifying drug delivery system; SNEDDS; Spontaneous emulsification; Valsartan

Indexed keywords

BIOCHEMISTRY; DRUG DELIVERY; EMULSIFICATION; SOLUBILITY; VEGETABLE OILS;

BIOAVAILABILITY; DRUG DELIVERY SYSTEM; SNEDDS; SPONTANEOUS EMULSIFICATION; VALSARTAN;

SURFACE ACTIVE AGENTS;

CASTOR OIL; COSURFACTANT; NANOCARRIER; POLYSORBATE 80; TRIACETIN; VALSARTAN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ISOLATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; EVALUATION STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; LIQUID LIQUID EXTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM; SYNTHESIS;

EID: 84897443886     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/15734137113096660107     Document Type: Article

References (20)

1. Cappello, B.; Di Maio, C.; Iervolino, M.; Miro A. Improvement of solubility and stability of valsartan by hydroxypropyl-betacyclodextrin. J. Incl. Phenom. Macrocycl. Chem., 2006, 54, 289-294.
2. Nayak, U.Y.; Shavi, G.V.; Nayak, Y.; Averinen, R.K.; Mutalik, S.; Reddy, S.M.; Gupta, P.D.; Udupa, N. Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system. J. Control. Release, 2009, 136, 125-131.
3. Jensen, C.E.; dos Santos, R.A.; Denadai, A.M.; Santos, C.F.; Braga, A.N.; Sinisterra, R.D. Pharmaceutical composition of valsartan: β-cyclodextrin: physico-chemical characterization and anti-hypertensive. Molecules, 2010, 15, 4067-4084.
4. Yan, Y.D.; Sung, J.H.; Kim, K.K.; Kim, D.W.; Kim, J.O.; Lee, B.J.; Yong, C.S.; Choi, H.G. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int. J. Pharm., 2012, 422, 202-210.
5. Flesch, G.; Müller, P.; Lloyd, P. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist in man. Eur. J. Clin. Pharmacol., 1997, 52, 115-120.
6. Gupta, A.K.; Mishra, D.K.; Mahajan, S.C. Preparation and in-vitro evaluation of self-emulsifying drug delivery system of antihypertensive drug valsartan. Int. J. Pharm. Life Sci., 2011, 2, 633-639.
7. Venkates Kumar, K.; Arunkumar, N.; Verma, P.R.P.; Rani, C. Preparation and in vitro characterization of valsartan solid dispersions using skimmed milk powder as carrier. Int. J. Pharm. Tech. Res., 2009, 1, 431-437.
8. Bondi, M.L.; Azzolina, A.; Craparo, E.F.; Capuano, G.; Nadia, L.; Gaetano, G.; Melchiorre, C. Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies. Curr. Nanosci., 2009, 5, 39-44.
9. Sood, S.; Jawahar, N.; Jain, K.; Gowthamarajan, K.; Meyyanathan, S.N. Olanzapine Loaded Cationic Solid Lipid Nanoparticles for Improved Oral Bioavailability. Curr. Nanosci., 2013, 9, 26-34.
10. Dixit, A.R.; Rajput, S.J.; Patel, S.G. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS Pharm. Sci. Tech, 2010, 11, 314-321.
11. Stegemann, S.; Leveiller, F.; Franchi, D.; de Jong, H.; Lindén, H. When poor solubility becomes an issue: From early stage to proof of concept. Eur. J. Pharm. Sci., 2007, 31, 249-261.
12. Shinde, R.L.; Jindal, A.B.; Devarajan, P.V. Microemulsions and nanoemulsions for targeted drug delivery to the brain. Curr. Nanosci., 2011, 7, 119-133.
13. Villar, A.M.; Naveros, B.C.; Campmany, A.C.; Trenchs, M.A.; Rocabert, C.B.; Bellowa, L.H. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int. J. Pharm., 2012, 431, 161-175.
14. Borhade, V.; Pathak, S.; Sharma, S.; Patravale, V. Clotrimazole nanoemulsion for malaria chemotherapy. Part I: Preformulation studies, formulation design and physicochemical evaluation. Int. J. Pharm., 2012, 431, 138-148.
15. Kelmann, R.G.; Kuminek, G.; Teixeira, H.F.; Koester, L.S. Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. Int. J. Pharm., 2007, 342, 231-239.
16. Kumar, M.; Misra, A.; Babbar, A.K.; Mishra, A.K.; Mishra, P.; Pathak, K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int. J. Pharm., 2008, 358, 285-291.
17. Khoo, S.M.; Humberstone, A.J.; Porter, C.J.H.; Edwards, G.A.; Charman, W.N. Formulation design and bioavailability assessment of lipidic selfemulsifying formulation of halofantrine. Int. J. Pharm., 1998, 168, 155-164.
18. Shafiq-un-Nabi, S.; Shakeel, F.; Talegaonkar, S.; Ali, J.; Baboota, S.; Ahuja, A.; Khar, R.K.; Ali, M. Formulation development and optimization using nanoemulsion technique: A technical note. AAPS Pharm. Sci. Tech., 2007, 8, 31-38.
19. Li, X.; Yuan, Q.; Huang, Y.; Zhou, Y.; Liu, Y. Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS Pharm. Sci. Tech, 2010, 11, 672-678.
20. Rohit, B.; Pal, K.I. A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs. Curr. Nanosci., 2009, 9, 211-220.